Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients in China
Overview
- Phase
- Not Applicable
- Intervention
- Not specified
- Conditions
- Endovascular Treatment
- Sponsor
- Tingyu-Yi
- Enrollment
- 2000
- Locations
- 6
- Primary Endpoint
- The modified Rankin Scale score at 90 days
- Status
- Recruiting
- Last Updated
- last year
Overview
Brief Summary
To investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.
Detailed Description
Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients is an academic,independent, pragmatic , prospective, multicenter, observational registry study. The acute ischemic stroke patients undergone endovascular therapy will be enrolled in stroke centers. Baseline information and clinical follow-up information at 90 days of stroke onset are collected. Data collected include demographics, comorbidities, pathogenesis, blood pressures, stroke severity on admission, time intervals, reperfusion condition, and functional outcome, et al. The study aims to investigate the real situation of assessment, diagnosis and treatment of acute ischemic stroke patients with endovascular therapy.
Investigators
Tingyu-Yi
Prospective Registry Study of Endovascular Treatment for Acute Ischemic Stroke Patients in China
Zhangzhou Municipal Hospital
Eligibility Criteria
Inclusion Criteria
- •Acute ischemic stroke;
- •Brain imaging confirmed intracranial large vessel occlusion: intracranial internal carotid artery (ICA), middle cerebral artery (MCA M1/M2), anterior cerebral artery (ACA A1/A2), basilar artery (BA), vertebral artery (VA V4), and posterior cerebral artery (PCA P1);
- •Initiation of any type of endovascular treatment, including mechanical thrombectomy, aspiration, angioplasty, and stenting;
- •Informed Consent as documented by signature or fulfilling the criteria for emergency consent/ deferral consent
Exclusion Criteria
- •Acute intracranial haemorrhage
- •No evidence of large vessel occlusion on digital subtraction angiography.
- •Patient bedridden or presenting from a nursing home
- •Foreseeable difficulties in follow-up due to geographic reasons (e.g. patients living abroad) -
Outcomes
Primary Outcomes
The modified Rankin Scale score at 90 days
Time Frame: 90 days
The range of the modified Rankin Scale is from 0 to 6. A higher score indicates a worse outcome. 0-No symptoms; 1-No significant disability; 2-Slight disability; 3-Moderate disability; 4-Moderately severe disability; 5-Severe disability; 6-Dead.
Secondary Outcomes
- symptomatic intracranial hemorrhage or death within 90 days after stroke onset.(90 days)
- Successful reperfusion rate(90 days)